Work

Supplementary Figure 3 from Novel Chemosensitive Single-Nucleotide Polymorphism Markers to Targeted Regimens in Metastatic Colorectal Cancer

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 1.4MB, Cell viability measured by MTT assay in transfected CRC clones (a. DFNB31 rs2274159; b. ANXA11 rs1049550; c. LINS1 rs11247226) treated with FRC (a), FRB (b), and FXB (c), respectively. Bold font, P < 0.05. FRC, FOLFIRI + cetuximab; FRB, FOLFIRI + bevacizumab; FXB, FOLFOX + bevacizumab.

DOI: 10.1158/1078-0432.22444829.v1

Authors: Jin C. Kim, Seon Y. Kim, Dong H. Cho, Ye J. Ha, Eun Y. Choi, Chan W. Kim, Seon A. Roh, Tae W. Kim, Hyoungseok Ju, Yong S. Kim

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362428126

Cites:

Cited by:

Related to: 10